RecallRadar

FDA Drug recall D-0849-2026

0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case

On 2026-09-09 the FDA classified a Class I recall of 0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case by Baxter Healthcare, citing presence of particulate matter: Particulates identified as fiberglass.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0849-2026
ClassificationClass I
Statusongoing
Initiated2026-08-17
Published2026-09-09
Last updated2026-09-23 05:30 UTC
CompanyBaxter Healthcare
Distributionn/a

Product

0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case. Baxter Healthcare Corporation, Deerfield, IL, 60015, USA, Made in USA, NDC 0338-0049-03

Reason

Presence of particulate matter: Particulates identified as fiberglass

Identifiers

ndc0338-0049-01
ndc0338-0049-02
ndc0338-0049-03
ndc0338-0049-04
ndc0338-0049-10
ndc0338-0049-41
ndc0338-0049-11
ndc0338-0049-31
ndc0338-0049-48
ndc0338-0049-18
ndc0338-0049-38
ndc0338-0043-03
ndc0338-0043-04
code_infoLot: Y495523, Y495523A, Exp 31-Oct-2027

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-23 05:30 UTC. Current status: ongoing.

Other recalls by Baxter Healthcare

All Baxter Healthcare recalls

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0849-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.